Opioid Continuing Education Requirement for Prescribers FAQ Effective January 1, 2020, all health care licensees who have authority to prescribe controlled substances must obtain two (2) hours of continuing education credits between January 1, 2020, and December 31, 2022.
Best Practices for Prescribing Opioids and Other Controlled Substances During the 2019 session, the Minnesota Legislature passed a law that requires individuals with licenses with the authority to prescribe controlled substances to obtain at least two hours of CME on best practices in prescribing opioids and controlled substances. To help physicians comply with this mandate, the MMA developed ...
Minnesota Board of Medical Practice 335 Randolph Avenue, Suite 140 St. Paul, MN 55102 Main Telephone Number: 612-617-2130 Fax Number: 612-617-2166 E-mail: [email protected] Details and Directions
During the 2019 session, the Minnesota Legislature passed a law that requires individuals with licenses with the authority to prescribe controlled substances to obtain at least two hours of CME on best practices in prescribing opioids and controlled substances. The CME must include content on: Best practices in prescribing opioids ; Non-pharmacological and implantable device alternatives for ...
During the 2019 session, the Minnesota Legislature passed a law that requires licenses with the authority to prescribe controlled substances to obtain at least two hours of CME on best practices in prescribing opioids and controlled substances.
Licensees are required to report completion of these two CME credits between Jan. 1, 2020 and Dec. 31, 2022.
This online activity is now available and is free for MMA members. The self-assessment activity can be taken whenever it’s convenient and will offer instant feedback including the answer, commentary and references for each item.
Improving Opioid Prescribing Opioid prescribers can play a key role in stopping the opioid overdose epidemic. Assessing risk and addressing harms of opioid use can save lives.
Study Summary: Co-Prescribing Naloxone and Medicare Part D Learn more about the national rates for naloxone co-prescription among Medicare Part D patients and why it’s important to educate clinicians, pharmacists and patients about when naloxone should be co-prescribed.
CDC Guideline for Prescribing Opioids for Chronic Pain Recommendations to help ensure patients have access to safer, more effective chronic pain treatment while reducing the risk of opioid use disorder, overdose, and death.
The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public workshop entitled “Reconsidering Mandatory Opioid Prescriber Education Through a Risk Evaluation and Mitigation Strategy (REMS) in an Evolving Opioid Crisis.” Convened by the Duke-Margolis Center for Health Policy and supported by a cooperative agreement between FDA and Duke-Margolis, the purpose of the public workshop is to give stakeholders an opportunity to provide input on aspects of the current opioid crisis that could be mitigated in a measurable way by requiring mandatory prescriber education as part of a REMS.
The public workshop will be held on October 13, 2021, from 1 p.m. to 5 p.m. Eastern Time and October 14, 2021, from 1 p.m. to 4:05 p.m. Eastern Time. Submit either electronic or written comments on this public workshop by December 3, 2021. See the SUPPLEMENTARY INFORMATION section for registration date and information.
Due to the impact of the COVID-19 pandemic, these meetings will be held virtually to help protect the public and limit the spread of the virus.
As FDA continues to work to address the opioid crisis, we are reconsidering our current efforts to ensure prescriber education regarding opioids is being delivered in a way that is as efficient and effective as possible.
2 credits in ethics, pain management, and/or addiction care and 2 credits in misuse and abuse of controlled substances, the prescribing of opioids, or addiction
2 hours every renewal on the safe and effective prescribing of controlled substance medications
12 hours in pain management and the treatment of terminally ill and dying patients. This course must also include the subject of the risks of addiction associated with the use of Schedule II drugs.
3 hours drug diversion training, best practices regarding prescribing of controlled substances, appropriate treatment for addiction, and any other matters pertaining to the prescribing of CDS that are deemed appropriate by the licensing board.
Many state medical boards require physicians to earn opioid CME credits to maintain their board license. With the misuse and abuse of prescribed opioid pain relievers on the rise, state medical boards want to ensure their licensed physicians are equipped to minimize the risk of opioid abuse. Opioid CME requirements can vary drastically by state so we have mapped out your state requirements below.
Oregon – 6 Credits. The Oregon Medical Board requires providers to undergo 6 credit hours in pain management. Pennsylvania – 2 Credits. The Pennsylvania State Board of Medicine requires 2 credit hours of pain management, the identification of addiction or the practices of prescribing or dispensing of opioids.
The New Jersey State Board of Medical Examiners requires 1 credit hour related to responsible opioid prescribing, alternatives to opioids for managing pain, risk and signs of opioid abuse, addiction and diversion. Regulations by the New Mexico Medical Board mandate 5 credit hours in management of the treatment of pain.
The New Hampshire Board of Medicine requires providers to undergo 3 credit hours in opioid prescribing for the management or treatment of pain, or for the treatment of opioid use disorder. New Jersey – 1 Credit.
The Nevada State Board of Medical Examiners requires licensees to undergo 2 credit hours of training in ethics, pain management, and/or addiction care. In addition, you must earn 2 credit hours in misuse and abuse of controlled substances, the prescribing of opioids, or addiction. New Hampshire – 3 Credits.
The Board of Registration in Medicine requires licensees to undergo 3 credit hours in pain management. Michigan – 3 Credits. The Michigan Board of Medicine requires licensees to undergo a minimum of 3 credit hours in pain and symptom management. Minnesota.
Delaware – 3 Credits, 2 topics. The Delaware Board of Medical Licensure and Discipline requires physicians to undergo 2 credit hours in controlled substance prescribing practices, treatment of chronic pain, or other topics relating to controlled substances.
Under Arkansas State Medical Board guidelines, practitioners must complete 1 credit hour in opioid training. Under the Medical Board of California, providers must undergo 12 credit hours in pain management and the treatment of terminally ill and dying patients.
During the 2019 session, the Minnesota Legislature passed a law that requires licenses with the authority to prescribe controlled substances to obtain at least two hours of CME on best practices in prescribing opioids and controlled substances.
Licensees are required to report completion of these two CME credits between Jan. 1, 2020 and Dec. 31, 2022.
This online activity is now available and is free for MMA members. The self-assessment activity can be taken whenever it’s convenient and will offer instant feedback including the answer, commentary and references for each item.